BDTX-189

• Description :

  BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations (KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively) . BDTX-189 exhibits anticancer activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  561.03

• Molecular Formula :

  C29H29ClN6O4

• Notes :

  Research use only, not for human use.

• Receptor :

  BLK|EGFR|HER2|RIPK2

• CAS Number :

  2414572-47-5